InTime: the results of Cortene’s CT38 trial
Cortene Inc., an American pharmaceutical company, recently published findings of a preliminary treatment trial in
A critical view into ME/CFS research
Cortene Inc., an American pharmaceutical company, recently published findings of a preliminary treatment trial in
In a previous blog post, we summarized the draft report of a systematic review on
Continue readingComments on the CDC evidence review on ME/CFS
The Centers for Disease Control and Prevention (CDC) have commissioned a systematic review on the
After years of waiting, the long-term follow-up results of the GETSET study have finally been
Continue readingWhat long-term follow-up data tell us about the evidence on GET and CBT
In a new blog series, we will investigate how illnesses were once thought to result
Continue readingA new blog series on the dark history of psychosomatic medicine
Canadian historian Edward Shorter is one of the most influential writers to have dismissed the
The Qure study was one of the largest randomized treatment trials for patients suffering from
On 25 November a new paper was published by David Tuller (University of California, Berkeley),
Continue readingA summary of our paper on exercise therapy and bias caused by lack of blinding
In a previous blog, Evelien and I argued that ME/CFS is getting less research funding
Continue readingWhy is ME/CFS getting so little research funding?
On 10 November 2020, the National Institute for Health and Care Excellence (NICE) released the
Continue readingCriticism of the 2020 NICE guideline draft: some things that could be improved